Home > Boards > US Listed > Medical - Healthcare > Johnson&Johnson (JNJ)

https://www.fool.com/investing/2020/03/30/johnson-johnson-to-invest-1-billion-in-covid-19-va.aspx

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
kingclever Member Profile
 
Followed By 59
Posts 3,852
Boards Moderated 0
Alias Born 06/01/04
160x600 placeholder
Pivotal Studies of Covid-19 Vaccines From AstraZeneca, J&J Resuming -- 3rd Update Dow Jones News - 10/23/2020 6:18:00 PM
Pivotal Study of J&J's Covid-19 Vaccine to Resume, Company Says Dow Jones News - 10/23/2020 5:13:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 10/23/2020 4:09:55 PM
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2020 PR Newswire (US) - 10/22/2020 2:16:00 PM
Covid-19 Vaccine Makers to Face Challenges When Recognizing Revenue Dow Jones News - 10/22/2020 5:59:00 AM
Banking on the Next Blockbuster Drug NetworkNewsWire - 10/20/2020 8:45:00 AM
J&J's Janssen Gets CHMP Positive Opinion for Tremfya in Active Psoriatic Arthritis Dow Jones News - 10/16/2020 8:36:00 AM
NIH to Study Three Drugs in Treatment of Covid-19 Patients Dow Jones News - 10/16/2020 7:59:00 AM
Companies Grapple With Sustainability Data -- Journal Report Dow Jones News - 10/13/2020 5:10:00 PM
J&J Hopes Covid-19 Vaccine Trial Will Restart Shortly Dow Jones News - 10/13/2020 2:07:00 PM
Johnson & Johnson Boosts Full-Year Forecast Dow Jones News - 10/13/2020 7:35:00 AM
Johnson & Johnson Reports Gains in 3Q Profit, Revenue Dow Jones News - 10/13/2020 7:29:00 AM
J&J Vaccine Pause Shows Challenges Still Ahead for Covid-19 Shots Dow Jones News - 10/13/2020 7:25:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/13/2020 7:13:23 AM
Johnson & Johnson Reports 2020 Third-Quarter Results PR Newswire (US) - 10/13/2020 6:39:00 AM
Johnson & Johnson Pauses Covid-19 Vaccine Trials Due to Sick Subject -- 2nd Update Dow Jones News - 10/12/2020 11:58:00 PM
Johnson & Johnson Pauses Covid-19 Vaccine Trials Due to Sick Subject -- Update Dow Jones News - 10/12/2020 11:16:00 PM
Johnson & Johnson Pauses Covid-19 Vaccine Trials Due to Sick Subject Dow Jones News - 10/12/2020 10:41:00 PM
How Two Compliance Officers Tackled Risks Arising From the Coronavirus Pandemic Dow Jones News - 10/8/2020 9:20:00 PM
Johnson & Johnson annonce l'approbation par la Commission européenne d'un accord visant à fournir 200 millions de doses du ... PR Newswire (Canada) - 10/8/2020 3:05:00 PM
Covid-19 Vaccine-Trial Volunteers Look to Make a Difference Dow Jones News - 10/8/2020 9:29:00 AM
European Commission Approves Purchase Agreement for 200 Million J&J Covid-19 Vaccine Doses Dow Jones News - 10/8/2020 8:35:00 AM
Johnson & Johnson Announces European Commission Approval of Agreement to Supply 200 Million Doses of Janssen's COVID-19 Vacci... PR Newswire (US) - 10/8/2020 8:23:00 AM
Johnson & Johnson Announces European Commission Approval of Agreement to Supply 200 Million Doses of Janssen's COVID-19 Vacci... PR Newswire (US) - 10/8/2020 7:50:00 AM
Johnson & Johnson Announces European Commission Approval of Agreement to Supply 200 Million Doses of Janssen's COVID-19 Vacci... PR Newswire (Canada) - 10/8/2020 7:50:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences